The Science Behind The ReGenisis Protocol
Discover the groundbreaking research supporting how psilocybin can reopen critical learning windows in the brain, catalyze neuroplasticity, and support both mental and physical recovery.
Psilocybin and Neuroplasticity: Opening Critical Learning Periods
Study: Ly et al., 2018 — “Psychedelics Promote Structural and Functional Neural Plasticity”
Why it matters: This pioneering study demonstrated that psilocybin promotes the growth of new dendritic spines and synapses in the brain. It suggests that psychedelics reopen critical learning periods, allowing the brain to rewire and adapt — a foundational mechanism behind why The Regenesis Protocol focuses on rewiring the brain to support healing from chronic illness and trauma.
Link: https://www.cell.com/neuron/fulltext/S0896-6273(18)30534-6
Psilocybin-Assisted Therapy for Depression and Anxiety
Study: Davis et al., 2020 — “Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder”
Why it matters: This clinical trial from Johns Hopkins showed that psilocybin-assisted therapy produced rapid and sustained decreases in depression and anxiety symptoms. It validates the power of psilocybin to shift deep-seated mental health patterns — which aligns with the mental-emotional recalibration in Regenesis.
Link: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2765210
Psilocybin and Functional Connectivity in the Brain
Study: Carhart-Harris et al., 2012 — “Neural Correlates of the Psychedelic State”
Why it matters: This classic neuroimaging study showed how psilocybin alters brain network connectivity, increasing global communication and flexibility. This enhanced connectivity underpins the ability to break rigid mental and physical patterns, a key element in the Regenesis Protocol’s approach to rewiring identity and health.
Psychedelic Therapy and Chronic Pain Relief
Study: Schindler et al., 2022 — “Psychedelic Treatment for Chronic Pain: A Review”
Why it matters: Chronic pain is often linked to neurological and energetic blockages. This review highlights emerging evidence that psychedelics can modulate pain perception and improve quality of life, reinforcing the potential for Regenesis to support people with chronic physical conditions.
Neuroinflammation Reduction via Psychedelic Therapy
Study: Szabo et al., 2021 — “Anti-inflammatory Effects of Psychedelics”
Why it matters: Chronic inflammation is a core factor in many chronic illnesses. This study found that psilocybin may reduce neuroinflammation, supporting physical recovery. This biochemical effect helps explain the physical healing aspect of Regenesis beyond just mental shifts.
Link: https://www.frontiersin.org/articles/10.3389/fphar.2021.644941/full
Psilocybin for PTSD and Trauma Healing
Study: Mithoefer et al., 2019 — “Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder”
Why it matters: This research demonstrated promising results using psilocybin and other psychedelics to reduce PTSD symptoms. Trauma leaves energetic and neurological imprints that Regenesis Protocol aims to recalibrate, making this an important scientific foundation for trauma-related healing.
The Role of Mindfulness and Meditation in Psychedelic Integration
Study: Garland et al., 2015 — “Mindfulness-Oriented Recovery Enhancement for Addiction and Chronic Illness”
Why it matters: Integration practices such as meditation strengthen new neural pathways created during psychedelic experiences. This aligns perfectly with the neuroscience-driven meditation protocols in Regenesis, which help consolidate healing at a deeper energetic and neurological level.